News and Trends 4 Oct 2022
Spinoff Biohaven launches with $258M and “incredible pipeline”
Biohaven Ltd. launched today as a new publicly traded company focused on delivering innovative life-changing treatments for neurological and neuropsychiatric diseases, including rare disorders. As of today, Biohaven has officially…